Loading clinical trials...
Loading clinical trials...
An Open-Label Single-Arm Study of Dupilumab in Adolescent and Adult Skin of Color Patients With Moderate-to-Severe Atopic Dermatitis
Conditions
Interventions
dupilumab
Topical emollient (moisturizer)
Locations
30
United States
Total Skin & Beauty Dermatology Center
Birmingham, Alabama, United States
The University Of Alabama At Birmingham
Birmingham, Alabama, United States
C2 Research Center, LLC
Montgomery, Alabama, United States
Center for Dermatology Clinical Research, inc.
Fremont, California, United States
UCSD/ Rady Children's Hospital
San Diego, California, United States
UCSF
San Francisco, California, United States
Start Date
January 11, 2023
Primary Completion Date
November 14, 2024
Completion Date
November 14, 2024
Last Updated
January 2, 2026
NCT07321951
NCT06453512
NCT03621137
NCT03057860
NCT06158490
NCT07438509
Lead Sponsor
Regeneron Pharmaceuticals
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions